Signal Peptide Peptidase: Biochemical Properties and Modulation by Nonsteroidal Antiinflammatory Drugs
- 27 June 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 45 (28) , 8649-8656
- https://doi.org/10.1021/bi060597g
Abstract
Signal peptide peptidase (SPP) is an intramembrane aspartyl protease that cleaves remnant signal peptides after their release by signal peptidase. SPP contains active site motifs also found in presenilin, the catalytic component of the γ-secretase complex of Alzheimer's disease. However, SPP has a membrane topology opposite that of presenilin, cleaves transmembrane substrates of opposite directionality, and does not require complexation with other proteins. Here we show that, upon isolation of membranes and solubilization with detergent, the biochemical characteristics of SPP are remarkably similar to γ-secretase. The majority of the SPP-catalyzed cleavages occurred at a single site in a synthetic substrate based on the prolactin (Prl) signal sequence. However, as seen with cleavage of substrates by γ-secretase, additional cuts at other minor sites are also observed. Like γ-secretase, SPP is inhibited by helical peptidomimetics and apparently contains a substrate-binding site that is distinct from the active site. Surprisingly, certain nonsteroidal antiinflammatory drugs known to shift the site of proteolysis by γ-secretase also alter the cleavage site of Prl by SPP. Together, these findings suggest that SPP and presenilin share certain biochemical properties, including a conserved drug-binding site for allosteric modulation of substrate proteolysis.Keywords
This publication has 57 references indexed in Scilit:
- Pseudomonas aeruginosa biofilm matrix polysaccharide Psl is regulated transcriptionally by RpoS and post‐transcriptionally by RsmAMolecular Microbiology, 2010
- Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III SecretionAntimicrobial Agents and Chemotherapy, 2010
- Regulatory RNAs and the HptB/RetS signalling pathways fine-tune Pseudomonas aeruginosa pathogenesisMolecular Microbiology, 2010
- Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies*Critical Care Medicine, 2009
- The Plant Phenolic Compound p -Coumaric Acid Represses Gene Expression in the Dickeya dadantii Type III Secretion SystemApplied and Environmental Microbiology, 2009
- Small-Molecule Type III Secretion System Inhibitors Block Assembly of the Shigella Type III SecretonJournal of Bacteriology, 2009
- Inhibition of Type III Secretion inSalmonella entericaSerovar Typhimurium by Small-Molecule InhibitorsAntimicrobial Agents and Chemotherapy, 2007
- Pseudomonas aeruginosa type III-secreted toxin ExoT inhibits host-cell division by targeting cytokinesis at multiple stepsProceedings of the National Academy of Sciences, 2006
- The Posttranscriptional Regulator RsmA Plays a Role in the Interaction between Pseudomonas aeruginosa and Human Airway Epithelial Cells by Positively Regulating the Type III Secretion SystemInfection and Immunity, 2006
- Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid dropletsThe EMBO Journal, 2002